These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 10861571)
1. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management. Cruz IB; Meijer CJ; Snijders PJ; Snow GB; Walboomers JM; van Der Waal I J Pathol; 2000 Jun; 191(2):132-7. PubMed ID: 10861571 [TBL] [Abstract][Full Text] [Related]
2. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901 [TBL] [Abstract][Full Text] [Related]
3. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia? Chen YK; Hsue SS; Lin LM Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192 [TBL] [Abstract][Full Text] [Related]
4. [P53 expression and clinical significance in oral squamous cell carcinoma]. Long Y; Ling D; Yue W Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases. Carlos de Vicente J; Junquera Gutiérrez LM; Zapatero AH; Fresno Forcelledo MF; Hernández-Vallejo G; López Arranz JS Head Neck; 2004 Jan; 26(1):22-30. PubMed ID: 14724903 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451 [TBL] [Abstract][Full Text] [Related]
7. Deregulated Bag-1 protein expression in human oral squamous cell carcinomas and lymph node metastases. Hague A; Packham G; Huntley S; Shefford K; Eveson JW J Pathol; 2002 May; 197(1):60-71. PubMed ID: 12081206 [TBL] [Abstract][Full Text] [Related]
8. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients. Ogmundsdóttir HM; Björnsson J; Holbrook WP J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450 [TBL] [Abstract][Full Text] [Related]
9. p53 expression in oral cancer: observations of a South Indian study. Pillay M; Vasudevan DM; Rao CP; Vidya M J Exp Clin Cancer Res; 2003 Sep; 22(3):447-51. PubMed ID: 14582705 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas. Shintani S; Yoshihama Y; Emilio AR; Matsumura T Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998 [TBL] [Abstract][Full Text] [Related]
11. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan. Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059 [TBL] [Abstract][Full Text] [Related]
12. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573 [TBL] [Abstract][Full Text] [Related]
13. Expression of p63 protein and mRNA in oral epithelial dysplasia. Chen YK; Hsue SS; Lin LM J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259 [TBL] [Abstract][Full Text] [Related]
14. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity. Sulkowska M; Famulski W; Chyczewski L; Sulkowski S Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700 [TBL] [Abstract][Full Text] [Related]
16. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188 [TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. de Oliveira LR; Ribeiro-Silva A; Zucoloto S J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296 [TBL] [Abstract][Full Text] [Related]
18. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. Tsai TC; Yu CH; Cheng SJ; Liu BY; Chen HM; Chiang CP Oral Oncol; 2008 Aug; 44(8):759-66. PubMed ID: 18061525 [TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma. Goulart Filho JA; Nonaka CF; da Costa Miguel MC; de Almeida Freitas R; Galvão HC Am J Otolaryngol; 2009; 30(2):89-94. PubMed ID: 19239949 [TBL] [Abstract][Full Text] [Related]
20. p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma. Kusama K; Okutsu S; Takeda A; Himiya T; Kojima A; Kidokoro Y; Chu L; Iwanari S; Kudo I; Moro I J Pathol; 1996 Apr; 178(4):415-21. PubMed ID: 8691320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]